Jay Gadsden

No ORCID on file · 1 paper in corpus
other 2023
Molecules (Basel, Switzerland) ·doi:10.3390/molecules28176330

The use of protease inhibitors in human immunodeficiency virus type 1 (HIV-1) treatment is limited by adverse effects, including metabolic complications. To address these challenges, efforts are underway in the pursuit of more potent and le…